Penetrium Bioscience Inc. (187660.KQ)
KOSDAQ · KRW · Healthcare · Medical Care Facilities
₩6,350 (+14.41%) as of
Key statistics
- Market cap
- 401.85B
- Dividend yield
- 0.00%
- 52-week range
- 2,325.00 – 21,500.00
- Beta
- 2.26
- Revenue (TTM)
- 9.74B
- Profit margin
- -206.22%
- Volume
- 1.56M
About Penetrium Bioscience Inc.
Penetrium Bioscience Inc., a contract research organization, provides clinical-related professional services for customer requirements in South Korea. The company offers clinical development services, such as medical writing, clinical operation, late phase study, data management, biostatistics, and regulatory affairs. It also provides pharmacovigilance services, which include case processing and safety reporting, safety and risk management plans, aggregate reporting, literature screening, and medical device vigilance; and quality assurance services. The company was formerly known as Hyundai ADM Bio Inc. and changed its name to Penetrium Bioscience Inc. in March 2026. Penetrium Bioscience Inc. was founded in 2003 and is based in Seoul, South Korea.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Headquarters
- Seoul, South Korea
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.